Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease

Archives of Neurology

Volumn 65, Issue 12, 2008, Pages 1640-1648

  Cuenco, Karen T ^a   Lunetta, Kathryn L ^a   Baldwin, Clinton T ^a   McKee, Ann C ^b   Guo, Jianping ^a   Cupples, L Adrienne ^a   Green, Robert C ^a,b   St George Hyslop, Peter H ^c,d   Chui, Helena ^e   DeCarli, Charles ^a,f   Farrer, Lindsay A ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; LIPOPROTEIN;

ADULT; AFRICAN AMERICAN; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN ATROPHY; BRAIN REGION; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; EVALUATION; FEMALE; GENE; GENETIC VARIABILITY; HAPLOTYPE; HIPPOCAMPUS; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; SORTILIN RELATED RECEPTOR GENE; VASCULAR DISEASE; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBROVASCULAR DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC;

EID: 61449117869     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.12.1640     Document Type: Article

References (45)

1. Andersen OM, Reiche J, Schmidt V, et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A. 2005;102(38):13461-13466.
2. Offe K, Doclson SE, Shoemaker JT, et al. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci. 2006;26(5):1596-1603.
3. Rogaeva E, Meng Y, Lee JH, et al. The sortilin-related receptor SORL1 is functionally and genetically associated with Alzheimer's disease. Nat Genet. 2007; 39(2):168-177.
4. Scherzer CR, Offe K, Gearing M, et al. Loss of apolipoprotein E receptor LR11 in Alzheimer disease [published correction appears in Arch Neurol. 2007;64(4):557].
5. Arch Neurol. 2004;61(8):1200-1205.
6. Dodson SE, Gearing M, Lippa CF, MontineTJ, Levey AI, Lah JJ. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol. 2006;65(9):866-872.
7. Lee JH, Cheng R, Schupf N, et al. The association between genetic variants in SORL1 and Alzheimer's disease in an urban, multiethnic, community-based cohort. Arch Neurol. 2007;64(4):501-506.
8. Lee JH, Cheng R, Honig LS, Vonsattel J-PG, Clark L, Mayeux R. The association between genetic variants in SORL1 and autopsy-confirmed Alzheimer's disease. Neurology. 2008;70(11):887-889.
9. Meng Y, Lee JH, Cheng R, St George-Hyslop P, Mayeux R, Farrer LA. Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport. 2007;18(17):1761-1764.
10. Webster JA, Myers AJ, Pearson JV, et al. Sorl1 as an Alzheimer's disease predisposition gene? Neurodegener Dis. 2008;5(2):60-64.
11. Tan E, Lee J, Chen CP, Teo Y, Zhao Y, Lee WL. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese [published online ahead of print December 4, 2007]. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2007. 10.013.
12. Li Y, Rowland C, Catanese J, et al. SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiol Dis. 2008;29(2):293-296.
13. Schmidt V, Sporbert A, Rohe M, et al. SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J BiolChem. 2007;282(45):32956-32964.
14. Sugiyama T, Kumagai H, Morikawa Y, et al. A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched β-VLDL in vitro. Biochemistry. 2000;39(51):15817-15825.
15. Ohwaki K, Bujo H, Jiang M, Yamazaki H, Schneider WJ, Saito Y. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages. Arterioscler Thromb Vasc Biol. 2007; 27(5):1050-1056.
16. Erlich PM, Lunetta KL, Cupples LA, et al; MIRAGE Study Group. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum Mol Genet. 2006;15(1):77-85.
17. Schneider JA, Boyle PA, Arvanitakis Z, Bienias JL, Bennett DA. Subcortical in-farcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007;62(1):59-66.
18. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004;62(7):1148-1155.
19. Thorisson GA, Smith AV, Krishnan L, Stein LD. The international Hap Map Project Web site. Genome Res. 2005;15(11):1592-1593.
20. Green RC, Cupples LA, Go RCPG, et al; MIRAGE Study Group. Risk of dementia among white and African American relatives of patients with Alzheimer's disease. JAMA. 2002;287(3):329-336.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34(7):939-945.
22. Roccaforte WH, Burke WJ, Bayer BL, Wengel SP. Validation of a telephone version of the Mini-Mental State Examination. J Am Geriatr Soc. 1992;40(7):697-702.
23. Yip AG, McKee AC, Green RC, et al. APOE, vascular pathology and the AD brain. Neurology. 2005;65(2):259-265.
24. T Cuenco K, Green RC, Zhang J, et al. Magnetic resonance imaging traits in siblings discordant for Alzheimer disease. J Neuroimaging. 2008;18(3):268-275.
25. DeCarli C, Maisog J, Murphy DG, Teichberg D, Rapoport SI, Horwitz N. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr. 1992;16(2):274-284.
26. Jagust WJ, Zheng L, Harvey DJ, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol. 2008;63(1):72-80.
27. Jack CR Jr, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 2002; 58(5):750-757.
28. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal aging: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967-972.
29. Lunetta KL, Erlich PM, T Cuenco K, et al; MIRAGE Study Group. Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE Study. Alzheimer Dis Assoc Disord. 2007;21(2):85-91.
30. SAS Institute Inc. Statistical Analysis System. Cary, NC: SAS Institute Inc; 2003.
31. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol. 2004;26(1):61-69.
32. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. PBAT: tools for family-based association studies. Am J Hum Genet. 2004;74(2):367-369.
33. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70(2):425-434.
34. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol Aging. 2005;26(4):491-510.
35. 34.Jeerakathil T, Wolf PA, Beiser A, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004;35(8):1857-1861.
36. Yoshita M, Fletcher E, Harvey D, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67(12):2192-2198.
37. Wu CC, Mungas D, Petkov CI, et al. Brain structure and cognition in a community sample of elderly Latinos. Neurology. 2002;59(3):383-391.
38. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215-1222.
39. Van Steen K, McQueen MB, Herbert A, et al. Genomic screening and replication using the same data set in family-based association testing. Nat Genet. 2005; 37(7):683-691.
40. Yamazaki H, Bujo H, Kusunoki J, et al. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J Biol Chem. 1996;271(40): 24761-24768.
41. Holtzman DM. In vivo effects of ApoE and clusterin on amyloid-β metabolism and neuropathology. J Mol Neurosci. 2004;23(3):247-254.
42. Xu PT, Li YJ, Qin XJ, et al. A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci. 2007;36(3):313-331.
43. Liu Q, Zerbinatti CV, Zhang J, et al. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron. 2007;56(1):66-78.
44. Jacobsen L, Madsen P, Jacobsen C, Nielsen MS, Gliemann J, Petersen CM. Activation and functional characterization of the mosaic receptor SorLA/LR11. J Biol Chem. 2001;276(25):22788-22796.
45. Seshadri S, DeStefano AL, Au R, et al. Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study. BMC Genet. 2007;8(suppl 1):S15.